MedTrace Logo

Vaccination for Children of H&O and Their Parents

NCT03373656 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2022-07-26

No results posted yet for this study

Summary

The purpose of this study is to study on compliance, safety and effectivity of vaccination for children with hematologic malignancies or solid tumors and their parents.

Conditions

  • Vaccination
  • Hematologic Malignancy
  • Solid Tumor, Childhood

Interventions

BIOLOGICAL

Vaccination

Patients with higher antibody titers will accept vaccination. There are two vaccines provided in this study: hepatitis B vaccine measles-rubella combined vaccine

OTHER

No Vaccination

Patients with higher antibody titers will NOT accept vaccination. But we will keep monitoring their antibody titers.

Sponsors & Collaborators

  • Shanghai Pudong District Center for Disease Control and Prevention

    collaborator UNKNOWN

  • Children's Cancer Group, China

    lead NETWORK

Principal Investigators

  • Yi-Jin Gao, MD · Shanghai Children's Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2025-07-31
Completion
2025-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03373656 on ClinicalTrials.gov